Global Biological Indicator Market Overview:
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
- Increasing Number of Surgical Procedures Globally
- Growing Number of Hospitals & Increasing Investment in Healthcare Infrastructure
- Lack of Awareness on Sterilization Monitoring
- The Growth of Pharmaceutical and Biotechnology Industry
- Dearth of Skilled Professionals
Some of the key players profiled in the report are 3M (United States), Steris Life Sciences (United States), NAMSA (United States), Mesa Laboratories Inc (United States), Terragene (Argentina), Advanced Sterilization Products (United States), SPSmedical (United States), BIoCI Systems, Inc. (United States), Cantel Medical Corporation (United States), Rubber Fab (United States), Getinge Group (Sweden), Propper Manufacturing Co. Inc. (United States), Astell (United Kingdom), Medline Industries (United States) and SIMICON GMBH (Germany). Considering Market by End User, the sub-segment i.e. Laboratories will boost the Biological Indicator market.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Biological Indicator market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Biological Indicator market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Biological Indicator Manufacturers, Biological Indicator Service Providers, Pharmaceutical, Biotechnology, and Medical Device Companies, Hospitals and Clinical Laboratories, Academic and Research Institutes and Regulatory Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.